Analyst Ratings for Can-Fite BioPharma (CANF)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2021 | Aegis Capital | Christian Anketell | New Coverage | Buy (N/A) |
5.00 (N/A) |
2.20 (1.96) |
-10.91% | Details |
| 6/13/2018 | H.C. Wainwright » Updated 9/24/2019 |
Vernon Bernardino | New Coverage | Buy (N/A) |
3.00 (30.00) |
1.30 (1.96) |
50.77% | Details |
 |
||||||||
|
||||||||
